Chapters:
1:30 Today’s cancer panels: do they hit the sweet spot?
6:15 On the need to test more widely
8:30 Are we better at handling these big panels today?
On tumor testing as opposed to germline testing… will it involve genetic counselors? “I think it will, or at least I think it should.”
19:00 Future gazing: Should we be testing all adults? AK says… not yet but perhaps soon.
Allison Kurian is Director of the Stanford Women’s Clinical Cancer Genetics Program, with a practice that centers on women at high risk of breast and gynecologic cancers. Trained in internal medicine, oncology, and epidemiology, Allison has embraced genetics (a fourth specialty!) as a tool for early detection and risk stratification.
Ten years after ACLU v Myriad changed the landscape of genetic testing overnight, how far have we come, and where are we headed next?
